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Background: Bovine tuberculosis (bTB) is a disease with major implications for animal welfare and productivity, as
well as having the potential for zoonotic transmission. In Great Britain (GB) alone, controlling bTB costs in the
region of £100 million annually, with the current control scheme seemingly unable to stop the inexorable spread of
infection. One aspect that may be driving the epidemic is evolution of the causative pathogen, Mycobacterium
bovis. To understand the underlying genetic changes that may be responsible for this evolution, we performed a
comprehensive genome-level analyses of 4 M. bovis strains that encompass the main molecular types of the
pathogen circulating in GB.
Results: We have used a combination of genome sequencing, transcriptome analyses, and recombinant DNA
technology to define genetic differences across the major M. bovis lineages circulating in GB that may give rise to
phenotypic differences of practical importance. The genomes of three M. bovis field isolates were sequenced using
Illumina sequencing technology and strain specific differences in gene expression were measured during in vitro
growth and in ex vivo bovine alveolar macrophages using a whole genome amplicon microarray and a whole
genome tiled oligonucleotide microarray. SNP/small base pair insertion and deletions and gene expression data
were overlaid onto the genomic sequence of the fully sequenced strain of M. bovis 2122/97 to link observed strain
specific genomic differences with differences in RNA expression.
Conclusions: We show that while these strains show extensive similarities in their genetic make-up and gene
expression profiles, they exhibit distinct expression of a subset of genes. We provide genomic, transcriptomic and
functional data to show that synonymous point mutations (sSNPs) on the coding strand can lead to the expression
of antisense transcripts on the opposing strand, a finding with implications for how we define a ‘silent’ nucleotide
change. Furthermore, we show that transcriptomic data based solely on amplicon arrays can generate spurious
results in terms of gene expression profiles due to hybridisation of antisense transcripts. Overall our data suggest
that subtle genetic differences, such as sSNPS, may have important consequences for gene expression and
subsequent phenotype.
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Mycobacterium bovis is the causative agent of bovine
tuberculosis (bTB), an endemic disease of cattle in
Great Britain (GB) with the potential for zoonotic trans-
mission to humans. In GB the primary control of bTB is
through ‘test and slaughter’ surveillance, whereby cattle
that are positive to the tuberculin skin test [1] are
removed from the herd and slaughtered. In spite of this
approach, which has been in place since the 1950s, the
number of TB-positive cattle slaughtered is increasing
year on year - approximately 30,000 cattle were tested and
slaughtered between 2012–2013, compared to 300 between
1995–1996 (http://www.defra.gov.uk/animal-diseases/a-z/
bovine-tb/). The UK (GB and Northern Ireland) govern-
ments currently spend approximately £100 million per
year collectively on control measures and compensation
to farmers for slaughtered cattle. The failure of the test-
and-slaughter policy to control the spread of infection
in large parts of GB suggests that we need a much
greater understanding of the TB disease dynamic, includ-
ing the role of pathogen diversity as a potential driver of
this process.
M. bovis isolates that are cultured from skin test-reactor
animals are currently genetically typed using a combination
of spoligotyping [2] and VNTR [3]. Spoligotyping exploits
a polymorphic region of the genome called the DR locus
which consists of multiple, identical 36bp repeats inter-
spersed with unique sequences known as spacers. Isolates
of M. bovis differ in the presence or absence of spacers
and adjacent DRs, allowing a ‘barcode’ to be generated for
each molecular type. Spoligotypes 9 and 17 are the domin-
ant molecular types in the UK, with more than one third
of all isolates corresponding to Type 9 and a quarter to
Type 17. VNTR measures the variation at repeat se-
quences in 6 regions of the genome. There are 6 major
VNTR types for Type 9, while all others show only one
dominant profile, suggesting that M. bovis Type 9
strains are more genetically variable compared with
other spoligotypes. Integration of molecular typing
with geographical information systems allows temporal
and spatial distribution of molecular types to be
mapped across GB. Type 9 isolates are widely distrib-
uted across GB, while type 17 is an emerging clone
which has expanded out of foci around Gloucester,
Hereford and Worcester. Similarly, Types 25 and 35
have expanded out of Staffordshire/Shropshire and
Hereford/Worcester, respectively. Between them, types
25, 35, 9 and 17 encompass the diversity of the major
clonal lineages of M. bovis circulating in the UK.
An analysis of molecular typing data from ~11,500
M. bovis isolates revealed that the population structure
of M. bovis in GB could not be explained by random
mutation and drift and instead, it appeared that certain
strains were increasing at a faster rate relative to others[4]. One suggestion for the ‘clonal expansion’ of GB
M. bovis genotypes was that certain genotypes had a
selective advantage over others leading to an increase
in their frequency in the population [4]. Supportive of
this hypothesis, several lines of evidence have suggested
that M. bovis isolates show phenotypic differences to
each other. Fourier-Transform Infrared Spectroscopy
(FT-IR) has been used to generate metabolic profiles of
the 10 major spoligotype groups of M. bovis isolates
circulating in GB. Clustering analysis of the resulting
spectra showed that the spectra could be differentiated
according to spoligotype, indicating that strains of dif-
ferent spoligotypes possess phenotypically distinct traits
[5]. In addition, it has also been shown that type 17 iso-
lates have lower incorporation rates of propionate into
membrane lipid components compared to other field
strains, suggesting a degree of metabolic remodelling in
the type 17 lineage [6]. Hence it appears that genetic
differences across M. bovis lineages may impact on
phenotypic traits. This latter finding may have import-
ant implications for vaccine and diagnostic test develop-
ment, in terms of which experimental challenge strains
to test vaccines against or on influencing diagnostic test
performance.
In an attempt to better define genetic differences
across the major M. bovis lineages circulating in GB
that may give rise to phenotypic differences of practical
importance, we have used a combination of genome
sequencing, transcriptome analyses, and recombinant
DNA technology. The genomes of three M. bovis field
isolates were sequenced using Illumina sequencing
technology and strain specific differences in gene ex-
pression were measured during in vitro growth and in
ex vivo bovine alveolar macrophages (Mϕ) using a
whole genome amplicon microarray. Recent discover-
ies of small non coding RNA within mycobacteria [7,8]
prompted us to assess differences in sRNA expression
across the isolates using a whole genome tiled oligo-
nucleotide microarray. SNP/small base pair insertion
and deletions (INDELs) and gene expression data were
overlaid onto the genomic sequence of the fully se-
quenced strain of M. bovis 2122/97 to link observed
strain specific genomic differences with differences in
RNA expression.
Results
Comparative genomics of M. bovis field isolates using
whole genome sequencing and microarrays
The strains for this study were chosen to reflect the
genomic diversity of the M. bovis population circulating
in GB, and are listed in Table 1. M. bovis strains were
typed using a combination of spoligotyping and VNTR.
For each spoligotype group, an isolate which possessed
the most common VNTR profile was selected, so that
Table 1 M. bovis field strains used in this study
AHVLA ID International spoligotype ID [9] UK spoligotype ID VNTR ID Year of isolation UK county of isolation
1121/01 SB0263 17 7555*33.1 2001 Wiltshire
2122/97 SB0140 9 8555*33.1 1997 Devon
2451/01 SB0129 25 6554*23.1 2001 Clwyd
1307/01 SB0134 35 3354*33.1 2001 Shropshire
*indicates partial number of repeats.
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spoligotype group (Table 1). Of the four studied strains,
2451/01 and 1307/01 diverged earliest during descent
from the most recent common ancestor of M. bovis in
GB and are more distant to strains 1121/01 and 1307/
01 (Smith, N. personal communication). All 4 strains
were isolated from diseased cows belonging to herds
which were taken from farms in geographically diverse
areas of the country.
The genomes of the three M. bovis strains 1121/01,
2451/01 and 1307/01 were paired-end sequenced using
Illumina sequencing technology. Processed sequence
reads were mapped to the genome of the fully sequencedFigure 1 Whole genome SNP-based evolutionary analysis of M. bovis
branches indicating the number of SNPs identified between the organism
number of SNPs present between selected pairs of strains.and annotated strain 2122/97 [10] to identify SNPs.
SNPs were identified across all four sequenced M. bovis
strains, and their positions, together with their SNP
class, are listed in Additional file 1. The evolutionary
relationships between the three sequenced strains are
depicted in Figure 1 using a phylogenetic tree and a
distance matrix plot. Three genome sequenced members
of the Mycobacterium tuberculosis complex, M. bovis
BCG Pasteur, M. tuberculosis H37Rv and M. africanum
GM041182, were included in the analysis to place the
M. bovis strains in a wider mycobacterial context. The
numbers of SNPs between M. bovis 2122/97 and the
three newly sequenced M. bovis strains were foundsequenced strains. (a). Phylogenetic tree with numbers above the
and its common ancestor. (b) Distance matrix plot showing the
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from each other. Strain 1121/01 (type 17) is most closely
related to the original genome sequenced strain 2122/97
(type 9) with 114 SNPs, whereas the more distantly related
strains 2451/01 (type 25) and 1307/01 (type 35) have 431
and 552 SNP differences respectively. All four sequenced
M. bovis strains were more distantly related to M.
africanum (~1800 SNPs) and M. tuberculosis H37Rv
(~2200 SNPs).
In addition to SNPs, both large and small INDELs can
be inferred from NGS data, although there are several
challenges involved [11]. Large sized insertions (>500
bp) are particularly difficult to identify with accuracy as
they require the de novo assembly of the reads that fail
to map to the reference genome and the subsequent
database searching with the resulting contigs. Accurate
identification of large sized deletions (>500 bp) are, how-
ever, more easily identifiable and Additional file 2 lists
those that have been identified by NGS in the genomes
of the three sequenced strains. As poor coverage can
confound the identification of deletions, we sought to
use microarray technology to confirm the deletions iden-
tified by the NGS data. Genomic DNA was isolated from
all four strains, labelled with fluorescent dyes and
hybridised to a whole genome M. tuberculosis/M. bovis
amplicon microarray (see Methods). Table 2 lists several
LSPs that were detected across the strains using
microarrays. Both NGS and microarray data predict the
presence of the large 6.8kb deletion (RDbovis(d)_0173)
which encompasses genes Mb1963-Mb1971 and appears
to be specific to UK strains belonging to Type 17 that
has been described in a previous study [12]. Several of
these gene products are predicted to encode proteins in-
volved in lipid metabolism, but the lipid composition of
several type 17 isolates was found to be no different to
other M. bovis strains, although their ability to incorpor-
ate propionate into mycolic acids was found to be lower
[6]. A smaller 1.6 kb deletion specific 1307/01 that com-
prises the 3′ end of Mb2056c, Mb2055c and the 5′ endTable 2 Large sequence polymorphisms present in M. bovis fi
Mb CDS Mtb CDS Genomic postn.
(wrt to 2122/97)
Size of
deletion (bp)
Gene(s) 2
Mb1699c Rv1627c n/d n/d
aMb1963c-
Mb1971
Rv1928c-
Rv1936
2172231-2179038 6807 tpx, fadE17,
fadE18, echA13
Mb2054c Rv2029c 2259798-2261457 1659 pfkB
Mb2055c/
Mb2056c
Rv2030c
Mb2320 Rv2298 n/d n/d
Mb3923c Rv3894c n/d n/d
DEL indicates genes that are deleted from strains.
aMostowy et al., 2005; n/d, not determined.of pkfB (Mb2054c) was also detected by both NGS and
microarray data, Due to a single base deletion, Mb2056c
and Mb2055c are pseudogenes in 2122/97, but the two
genes exist as one intact functional gene in 2145 and
H37Rv (Rv2030c). The pfkB gene encodes a phospho-
fructokinase homologue and is strongly immunogenic in
human TB patients, while Rv2030c encodes an erythro-
mycin esterase. Both pfkB and Mb2056c are members of
the DosR regulon, which are highly upregulated under
anaerobic conditions and have been implicated in bac-
terial persistence in vivo [13]. Other smaller deletions
detected include a deletion of a probable lipid transfer
protein encoding gene Mb1699c, which is specific to
1307/01, and an aldo/keto reductase encoding gene,
Mb2320 that is specific to 1121/01.Linking SNPs to genes that show differential expression
amongst M bovis strains grown under vitro conditions
and in ex vivo macrophages
The four M. bovis field strains were grown to mid-
logarithmic phase in pyruvate-containing Middlebrook
7H9 liquid media, and then used to infect bovine alveo-
lar Mϕ using a multiplicity of infection (MOI) of 10:1
(bacilli: Mϕ). Mycobacterial RNA was recovered from
infected host cells 4 and 24 hrs post infection using a
differential lysis procedure and amplified using a modi-
fied procedure similar to that described by van Gelder
et al. ([14]; see Methods). As a control, RNAs were also
extracted from strains that had been incubated statically
in RPMI cell culture media for a period of 4 hrs. To
eliminate potential skewing effects on the transcriptome
resulting from the amplification process, comparisons
were made only between amplified RNA generated from
samples collected at the same time point and biological
replicate. For the in vitro growth condition, total RNAs
were extracted from the four strains grown in a pyruvate-
containing Middlebrook 7H9 liquid media and rolled
during incubation.eld isolates
122/97 1121/01 2451/01 1307/01 Product(s)
DEL Probable lipid transfer protein
DEL Gene products have roles in
lipid metabolism
DEL Possible phosphofructokinase
DEL Conserved hypothetical protein
(frame-shifted in 2212/97)
DEL DEL Aldo/keto reductase
DEL Conserved membrane protein
(frame-shifted in 2212/97)
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tions were converted to cyanine labelled cDNA using re-
verse transcriptase and hybridised to whole genome
amplicon microarrays. Using only those genes that are
common to all four strains, we found a total set of 70
genes that showed a 2.5-fold or more difference in ex-
pression in one or more strains when pairwise compari-
sons were made between the transcriptomes of 2122/97
and 1121/01, 2451/01 or 1307/01 (Additional file 3). A
subset of these 70 genes is shown in Table 3 where key
examples of alterations in metabolic processes are
shown. The numbers of genes that were found to show
differential expression across the four strains reflected
the evolutionary distances between 2122/97 and the
other 3 strains. Thus, 1121/01, which is closely related
to 2122/97, shows only 5 differentially expressed genes,
while the most distantly related strain 1307/01 shows 56
genes differently expressed compared to 2122/97. Of
these 56 genes, 5 were specific to the in vitro condition,
while 19 were specific to the Mϕ. Ten genes were com-
mon to both conditions, which serves to validate the
technical reproducibility of the RNA amplification
process.
Using the genome sequencing information determined
for each of the four strains, we attempted to correlate
the observed strain-specific differences in gene expres-
sion with the presence or absence of mutations within
the coding regions or promoters of those genes that
show differential gene expression, or in genes that are
known to regulate the activity of those genes. Mb1749c
and Mb1750c are two genes that are specifically
upregulated in 1307/01 and encode a toxin and antitoxin
(TA) pair, respectively, belonging to type II TA systems
of the VapBC family [15]. Members of VapB type toxins
contain PIN domains that cleave RNA and thus function
to control translation of mRNA transcripts [16]. The
homologous genes from strain 1307/01 show up to 19-
and 10-fold higher levels of expression, respectively, than
those of the other three strains. An analysis of the cod-
ing sequences of Mb1749c across all four strains re-
vealed that the 1307/01 homologue has a unique nSNP
at position 1932704 (wrt 2122/97 genomic sequence), a
C-T transition that results in the nonconservative substi-
tution of Gly19 to Asp. Research has shown that TA
gene pairs negatively regulate their own expression
through binding of the TA protein complex to the pro-
moter region of the TA gene pair, thus preventing access
to RNA polymerase [17]. The G19D mutation in
Mb1749c could therefore impair the ability of the com-
plex to bind to the promoter resulting in the deregula-
tion of the TA gene pair.
Mb2007c, which shows a 4-fold higher expression in
1307/01 only, encodes a transcriptional regulator of the
LysR class. There are two SNPs present in the codingsequence of Mb2007c in 1307/01 which are absent in
the homologues of the other three strains: the first is a
nSNP which results in the conservative substitution of
Arg137 to Gln, while the second is a more debilitating
nonsense SNP, which ultimately leads to a protein whose
length is only 60% that of the wild-type. Many regulators
belonging to the LysR family regulate their own expres-
sion through a negative autoregulatory mechanism simi-
lar to that described above for VapBC TA systems [18].
A loss in protein integrity could, therefore, result in the
regulator being unable to bind the regulatory region,
leading to the observed upregulation in the expression
of this gene in 1307/01. As the product of this gene is
predicted to be a transcriptional regulator, it was specu-
lated that the regulation of gene(s) controlled by regula-
tor could be affected in 1307/01 due to the severely
truncated form of this protein. As LysR regulators are
often found to regulate genes that are divergently tran-
scribed from the lysR gene, it was surprisingly to find
that expression of the Mb2008 homologue in 1307/01,
which is predicted to encode a lysine transporter, does
not show any difference in expression in 1307/01 to
2122/97. To define the regulon of this regulator, we first
compared the transcriptomes of 2122/97 transformed
with a multicopy plasmid expressing the truncated copy
of mb2007c against a vector only control. No differences
in expression were found (data not shown), which could
indicate that the regulator does not control any other
genes apart from itself, or that experimental conditions
did not favour the active form of the regulator. LysR reg-
ulators regulate expression of their regulon through
binding of a co-inducer to the C-terminal domain, and
the failure to observe any changes in gene expression
could therefore be due to the absence of the co-inducer
during the experiment. A further experiment to compare
the profiles of 2122/97 expressing either the truncated
or wild type forms of the protein also showed no differ-
ences in expression (data not shown).
Nitrite reductase catalyses the reduction of nitrite to
ammonia and is strongly expressed during growth in the
presence of nitrate or nitrite, but repressed in the pres-
ence of ammonia [19]. The gene encoding the large sub-
unit of the nitrite reductase, nirB (Mb0258), shows
approximately 9-fold higher expression in 1307/01 com-
pared to the other 3 strains in our standard ammonia
containing 7H9 growth media, suggesting that the strain
has lost regulatory control of this gene. Expression of
nirB in M. tuberculosis has been shown to be controlled
by the response regulator GlnR [20], but an analysis of
the sequence of the glnR orthologue from all four strains
revealed no differences in either the coding or promoter
sequences. A comparison of the nirB sequence from all
4 strains did, however, reveal the presence of a single
base (C to T) transition leading to a sSNP that is specific
Table 3 Fold change differences in gene expression in M. bovis field isolates 1121, 2451 and 1307 compared to 2122
Mb CDS Mtb CDS Common 1121/01 2451/01 1307/01 Product Assoc. SNP/InDel
7h9 RPMI 4hr MØ 24 hr MØ 7h9 RPMI 4hr MØ 24 hr MØ 7h9 RPMI 4hr MØ 24 hr MØ
Mb0038c Rv0037c 4↑ 3↑ 3↑ probable conserved
integral membrane
protein
Mb0124c Rv0120c fusA2 3↑ 3↑ probable elongation
factor
Mb0258 Rv0252 nirB 9↑ 12↑ 21↑ 9↑ nitrite reductase
(large subunit)
sSNP at postn. 303227 in 1307/01
only; C-T;
Mb0259 Rv0253 nirD 3↑ 4↑ 5↑ nitrite reductase
(small subunit)
Mb0428c Rv0420c 2↑ possible
transmembrane
protein
Mb0734 Rv0713 2↑ probable conserved
transmembrane
protein
Mb0947c Rv0923c 2↓ 2↓ conserved
hypotheitical protein
Mb0948c Rv0924c mntH cation uptake system
Mb1013;
Mb1014
Rv0987 5↑ 10↑ 5↑ 5↑ 7↑ 6↑ probable adhesion
component transport
ABC transporter
nSNP at postn. 1104263 in 2451/01 and
1307/01; A-G (STOP to W); sSNP at
postn 1103991 in 2451/01 and 1307/01
Mb1015 Rv0988 3↑ 9↑ 3↑ 5↑ 5↑ possible conserved
exported protein
Mb1161 Rv1130 2↓ conserved
hypothetical protein
Mb1162 Rv1131 gltA1 3↓ probable citrate
synthase
Mb1554c Rv1527c pks5 2↓ probable polyketide
synthase
Mb1562 Rv1535 2↑ 5↑ hypothetical protein
Mb1619c Rv1593c 2↑ conserved
hypothetical protein
Mb1749c Rv1720c 10↑ 19↑ 18↑ 12↑ conserved
hypothetical protein
nSNP at postn. 1932704 in
1307/01 only ; C-T (G to D)
Mb1750c Rv1721c 6↑ 3↑ 9↑ 5↑ conserved
hypothetical protein
Mb1833c Rv1804 3↓ conserved
hypothetical protein
Mb1834c Rv1805c 4↑ hypothetical protein
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Table 3 Fold change differences in gene expression in M. bovis field isolates 1121, 2451 and 1307 compared to 2122 (Continued)
Mb1835 Rv1806 PE20 3↑ PE family protein
Mb1885c Rv1854c ndh 3↓ probable nadh
dehydrogenase
Mb1914c Rv1882c 6↑ 3↑ 6↑ probable short-chain
type dehydrogenase/
reductase
sSNP at postn 2122970 in
2415/01 only: C-T
Mb2007c Rv1985c 4↑ 3↑ 3↑ probable
transcriptional
regulatory protein
nSNP at postn. 2208296 in 1307/01
only; G-A (Q to Stop)
Mb2015c RV1992c ctpG 2↓ 3↓ probable cation
transporter
Mb2420c Rv2398c cysW 2↓ 6↓ sulphate transporter
Mb2421c Rv2399c cysT 2↓ 4↓ sulphate transporter
Mb2607 Rv2577 9↓ 5↓ 7↓ 12↓ 10↓ 7↓ 7↓ 13↓ conserved
hypothetical protein
[first part]
Mb3194 Rv3169 3↑ 3↑ 2↑ 3↑ conserved
hypothetical protein
Mb3477c Rv3447c 8↓ 3↓ 10↓ 9↓ 2↓ 7↓ probable conserved
membrane protein
nSNP at postn. 3812465 in 2451/01
and 1307/01; T-C (S to G)
Mb3563c Rv3533c PPE62 5↑ 5↑ ppe family protein
Mb3721c Rv3696c glpK 3↓ glycerol kinase
Mb3803 Rv3774 echA21 8↑ 7↑ 22↑ possible enoyl-coA
hydratase
sSNP at postn. 4155803 in
2415/01 only; G-A
Up and down arrows indicate fold up- and downregulation, respectively, and empty cells indicate no change in expression.
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http://www.biomedcentral.com/1471-2164/14/710to 1307/01. It was not readily apparent why a sSNP in the
coding sequence of a gene should lead to an increase in
expression of that gene, but there are several reports that
show sSNPs leading to changes in stability of mRNA tran-
scripts [21,22]. Rv0987 and Rv0988 of M. tuberculosis
H37Rv encode part of an ABC transporter and a putative
secreted hydrolase, respectively. In 2122/97, a single base
transition (G-A) introduces a stop codon that splits
Rv0987 into the two pseudogenes, Mb1013 and Mb1014.
Previous microarray based gene expression studies by our
group have shown that Rv0987 and Rv0988 in M. tubercu-
losis show higher levels of expression than the orthologous
Mb1013/Mb1014 and Mb1015, respectively, in M. bovis
2122/97 [23], and in the present study the Mb1013/
Mb1014 and Mb1015 homologues in 2451/01 and 1307/
01 also showed higher expression (up to 10-fold) than the
homologues in 2122/97 and 1121/01. Comparing the
sequences of Mb1013/Mb1014 and Mb1015 across all 4
strains indicated that strains that show high expression
have the ‘G’ allele.
Mb3477c encodes an ATP binding membrane protein,
part of the Esx4 secretion system [24], and gene shows up
to 10-fold higher expression in 2451/01 and 1307/01 com-
pared to 2122/97. The gene also contains an A to C transi-
tion at position 3812465, a nSNP at position resulting in
the non-conservative substitution of a serine to a glycine
residue.Figure 2 Confirmation of amplicon microarray results with real time R
(c) echA21 and (d) Mb1914c measured by microarray (open bars) in each o
(closed bars).Of the 19 genes that show specific differential expres-
sion in the Mϕ, the most notable are Mb1914c and
echA21, which show upregulation in 2451/01 only (up
to 6- and 23-fold, respectively). Both genes encode
proteins that could be involved in lipid metabolism, and
both genes contain single sSNPs that are present in
2451/01, but absent in the other three strains.
Real time RT-PCR was used to verify a selection of
genes that showed differential gene expression as pre-
dicted by the microarray analysis. Figure 2 compares
the fold changes in the expression levels of 4 genes as
measured by microarray and real time RT-PCR. The
nirB and Mb1749c genes were selected because they
showed strong upregulation in 1307/01 in both in vitro
and ex vivo Mϕ while Mb1914c and echA21 were chosen
because the array data predicted them to be specifically
upregulated in 2451/01 and only in ex vivo Mϕ. For
each of the 4 genes, the strain dependent pattern of
expression as measured by real time RT-PCR was consistent
with that measured by microarray, although the fold
changes measured by real time RT-PCR were higher
than those measured by microarray.
Functional analysis of SNP role in differential gene
expression
The above data showed that many of the strain specific
differences in gene expression were linked to the presenceT-PCR. The fold changes in gene expression for (a) Mb1750c, (b) nirB,
f the four strains were compared to that measured by real time RT-PCR
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the coding regions of the genes that show variable expres-
sion. Non-synonymous SNPs lead to changes in amino
acid sequence which can lead to changes in protein func-
tion. The C to T transition at position 1932704 (wrt 2122/
97) in the coding sequence of the 1307/01 Mb1749c
homologue leads to the non-conservative substitution of
Gly19 to Asp, and this nSNP appears to be linked to the
upregulation of both Mb1749c and Mb1750c in that
strain. In order to confirm this, a 0.9 kb DNA fragment
containing the Mb1749c-Mb1750c-‘MB1751c region of
1307/01 (containing the ‘T’ allele) and the equivalent
region from 2122/97 (with the ‘C’ allele) were PCR
amplified and the fragments were cloned separately
into the mycobacterial shuttle vector pKINT (see Methods)
to create the constructs pPG107 and pPG106, respectively.
The two constructs were introduced into Mycobacterium
smegmatis mc2155, separately, and then the expression of
Mb1749c and Mb1750c in M. smegmatis pPG101 was
compared to that of M. smegmatis pPG102 using real time
RT-PCR. Table 4 shows that the expression levels of
Mb1750c and Mb1749c in the strain expressing the
mutated forms of Mb1749c/Mb1750c are 13- and 9-fold
higher, respectively, compared to the strain expressing
the wild type forms, confirming that this SNP is respon-
sible for the observed up-regulation of the two genes in
1307/01.
Synonymous substitutions do not lead to changes in
protein sequence and have generally been considered to
be ‘silent’ or benign. Recent studies, however, have sug-
gested that sSNPs can have functional effects, such as
decreased mRNA stability and translation [21,22]. In
our own studies, we have found several genes whose ex-
pression levels correlate with the presence of sSNPs in
the coding regions of those genes. For example, a C-T
transversion at position 303227 (wrt 2122/97) within
the coding sequence of nirB of 1307/01 is a sSNP that
appears to be linked with the upregulation in expression
of nirB within that strain. To confirm that this is the
case, we PCR amplified 3.5 kb DNA fragments containingTable 4 Confirmation of SNP linkage to upregulation in
gene expression
Strain Gene Fold change*
M. smegmatis mc2155 (pPG101) Mb1750c 16.1 ± 3.2
M. smegmatis mc2155 (pPG101) Mb1749c 12.5 ± 1.2
M. smegmatis mc2155 (pPG102) Mb1750c 1.9 ± 0.8
M. smegmatis mc2155 (pPG102) Mb1749c 1.4 ± 0.4
Mb 2122/97 (pPG108) nirB 2.0 ± 1.0
Mb 2122/97 (pPG108) nirD 1.3 ± 0.5
Mb 2122/97 (pPG109) nirB 52.9 ± 15.9
Mb 2122/97 (pPG109) nirD 3.1 ± 0.8
*Fold changes are the mean ratios ± standard deviation.the hsp-nirB-nirD-cobU region of strain 1307/01 (containing
the ‘C’ allele) and the equivalent region from strain 2122/97
(with the ‘T’ allele) and cloned them separately into the
integrating vector pKINT to create the constructs
pPG108 and pPG109, respectively. These constructs
were introduced into 2122/97 and the expression levels
of nirB and nirD were found to be 30- and 2-fold, re-
spectively, higher in the strain expressing the mutated
nirBD locus compared to the strain expressing the wild-
type form (Table 4). This confirms that this mutation is
responsible for the upregulation of the two genes in this
strain.
Use of a high density tiled oligonucleotide microarray to
detect differentially expressed small RNA transcripts in
M. bovis isolates
The M. tuberculosis/M. bovis amplicon arrays used in
the present study were specifically designed to measure
expression levels of genes annotated in the genomic se-
quence of M. bovis 2122/97 [10]. They were not, how-
ever, designed to monitor the expression of non-coding
RNA such as small RNA within intergenic regions or
antisense sRNA. Hence, a high density tiled oligonucleotide
microarray consisting of approximately 180,000 partially-
overlapping (10-base overlap) short 60 mer oligonucleo-
tides was designed that offered an unbiased approach to
the detection of strand specific transcripts encoded over
the entire M. bovis 2122/97 chromosome. Total RNA
that includes small sized (<100 nt) RNA species was
extracted from the four M. bovis strains that had been
grown in liquid media and hybridised to the oligo-
nucleotide microarray. To avoid potential secondary
strand synthesis during cDNA synthesis, which could
be interpreted as sRNA, the RNA was directly labelled
with cyanine based dyes. After pairwise comparisons
were performed between 2122/97 and 1121/01, 2451/01
or 1307/01, 220 oligonucleotide probes were identified
that detected differentially expressed transcripts (2.5 fold
cut off ) in one or more of the three strains (Additional
file 4). Only transcripts detected by multiple (2 or more)
overlapping probes were regarded as genuine transcripts
as those detected by single probes could be due to cross-
hybridisation effects or represent spurious transcripts.
Using these criteria, 26 transcripts, designated T1-T26,
were found to show differential expression in one or more
of the strains (Table 5), and those transcripts can be di-
vided into those that are encoded within intergenic re-
gions and those encoded within the genomic co-ordinates
encompassing annotated coding sequences. Comparison
of the differentially expressed gene lists identified using
amplicon vs. oligonucleotide arrays (Tables 3 and 5), it
is clear that many of the transcripts detected using the
amplicon arrays are not necessarily encoded on the
sense gene strand, as had been previous interpreted. For
Table 5 Differential expression of RNA transcripts as detected by a tiled oligonucleotide microarray
Transcript No. Probes Position Size cds Strand* 1121/01 2451/01 1307/01 CDS Product SNP
T1 3 303138-303295 157 Mb0258/nirB A 3↑ nitrite reductase (large sub-unit)
T2 5 303260-303515 255 Mb0258/nirB S 5↑ nitrite reductase (large sub-unit) sSNP at 303227; C-T in 1307/01 only
T3 2 1105085-1105193 108 Mb1014 A 3↑ 3↑ probable adhesion component
of ABC transporter
T4 2 1105158-1105315 157 Mb1014 A 3↑ 3↑ probable adhesion
component of ABC transporter
T5 3 1105158-1105315 157 Mb1014 S 3↑ 3↑ probable adhesion
component of ABC transporter
T6 5 1778876-1779131 255 Mb1618c A 9↑ possible secreted lipase sSNP at 1778879; C-T in 1121/01 only
T7 2 1840174-1840282 108 Mb1672c S 4↓ hypothetical protein
T8 3 1932158-1932315 157 tRNA-Pro S 3↑ proline tRNA
T9 5 1932452-1932707 255 Mb1749c S 4↑ toxin component of
toxin-antitoxin system
nSNP at 1932704; C-T (G to D) in 1307/01 only
T10 5 1932746-1933075 329 Mb1750c S 7↑ anti-toxin component of
toxin-antitoxin system
T11 6 2122959-2123263 304 Mb1914c A 12↑ probable short-chain type
dehydrogenase/reductase
sSNP at 2122970; C-T in 2451/01 only
T12 2 2324463-2324571 108 Mb2110 S 3↑ hypothetical protein
(frame-shifted in 2122/97)
T13 2 2328944-2329052 108 Mb2116c/pepE S 2↓ 3↓ probable dipeptidase
T14 2 2329483-2329591 108 Mb2117 A 10↓ 10↓ 5′-3′ exonuclease nSNP at 2329583; A-G (comp. strand; I to T)
in 2451/01 only
T15 3 2868310-2868467 157 Mb2607 A 6↓ 8↓ hp (frame-shifted in 2122/97)
T16 2 2868506-2868614 108 Mb2607 A 7↓ 7↓ hp (frame-shifted in 2122/97) nSNP at 2868616; A-G (stop to W) in
2451/01 and 1307/01;
T17 2 3075740-3075848 108 I 5↑ 6↑
T18 2 3075887-3075995 108 I 5↑ 6↑
T19 2 3076622-3076730 108 I 4↑ 4↑
T20 2 3076769-3076877 108 I 5↑ 5↑
T21 2 3078728-3078836 108 I 6↑ 7↑
T22 2 3079169-3079277 108 I 4↑ 6↑
T23 2 3079903-3080011 108 I 6↑ 7
T24 2 3844577-3844685 108 Mb3509c S 3↑ 3↑ possible acyltransferase
(frame-shifted in 2122/97)
T25 6 4155501-4155805 304 Mb3803/echA21 A 5↑ possible enoyl-coA hydratase sSNP at 4155803; C-T (comp. strand) in 2451/01 only
T26 2 4316987-4317095 108 Mb3927c A 3↑ chp (frame-shifted in H37Rv)
Up and down arrows indicate fold up- and downregulation, respectively, and empty cells indicate no change in expression.
*Strand, A indicates antisense, S, sense and I, intergenic.
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that Mb1914c and echA21 were upregulated in 2451/01,
but the oligo array data indicates that transcripts 11 and
25, which are encoded within the co-ordinates encoded by
those two genes, are actually encoded on the antisense
strands. This apparent discrepancy can be rationalised
once we consider that double stranded amplicon micro-
array probes cannot discriminate between transcripts
encoded on the sense or antisense strands. Transcripts 11
and 25 can therefore be considered as potential antisense
sRNAs (asRNA), which could be involved in translational
or post-transcriptional control of the sense transcript.
Other potential cis-encoded sRNAs detected using the ar-
rays include T6, T14, and T15/T16 which are encoded on
the antisense strands to Mb1618c, Mb2117 and Mb2607,
respectively, and for each of these transcripts, their expres-
sion appears to be linked to the presence of a single SNP
within the co-ordinates of the genes. The approximate
boundaries of these transcripts can be derived from the
genomic co-ordinates of the oligonucleotide probes that
detect the expression of the transcript. Thus, the tran-
scripts appear to be between 100–300 nt in size and the
positions of the linked SNPs appear to be positioned either
just upstream or within the predicted 5′end of the tran-
scripts (Figure 3). Three of the transcripts (T11, T14 and
T25) are antisense to the central part of the sense encoded
gene, while T6 is encoded antisense to the 5′ end of
Mb1618c. As well as antisense transcripts, we also saw the
differential expression of sense transcripts. The amplicon
microarray data (confirmed by real time RT-PCR) indi-
cated that nirB is strongly upregulated specifically in
1307/01 in both in vitro and ex-vivo Mϕ. An analysis of
the oligonucleotide array data, however, indicates that
there are two short transcripts, T1 and T2 (sense and anti-
sense, respectively) that are encoded within the genomic
co-ordinates of the nirB gene. T2 is the longer in size (255
vs. 155nt) and more highly expressed (5 vs. 3-fold) than
T1, and both transcripts appear to be linked to the pres-
ence of a SNP that is located within the middle of T1 and
approximately 50nt upstream of T2.
Some of the transcripts are bone fide gene sense
strand mRNA transcripts, such as T9 and T10 which
are encoded by Mb1749c and Mb1750c, respectively.
Although it would appear that the two genes are tran-
scribed separately, it is probable that the two transcripts
are co-transcribed as the stop codon of Mb1750c over-
laps the start codon of Mb1749c. Eight of the tran-
scripts listed in Table 5 are encoded within intergenic
regions, 7 of which are encoded within the polymorphic
direct repeat (DR) locus. The DR locus of strains belong-
ing to the M. tuberculosis complex has been suggested to
constitute a CRISPR locus which have been shown in
many species of bacteria to be involved in protection
against exogenous foreign DNA such as plasmids andphage [25]. All the DR encoded transcripts are short
(approx. 100 nt), straddle contiguous repeat and spacer
sequences and show approximately 5-fold higher levels
of expression in 2451/01 and 1307/01 compared with
2122/97 and 1121/01.
Characterisation of differentially expressed cis asRNA
The genomic co-ordinates of the oligonucleotide probes
that detected the antisense species described above can
only serve as approximate estimations as to their start
and end points. Thus, we used 5′ RLM-RACE (RNA
Ligase Mediated Rapid Amplification of cDNA Ends) in
an attempt to accurately define the transcriptional start
sites (TSS) for the short sense transcript T2, and the anti-
sense transcripts T6, T11 and T25 described in the above
section (see Methods). These transcripts were chosen as
their expression levels are high and their transcript lengths
were considered to be sufficiently long to enable the
RLM-RACE methodology to work. Table 6 details the
sizes of the PCR products obtained after RLM-RACE was
performed using oligonucleotide primers designed to
sequences predicted for transcripts T6, T11 and T25. No
PCR product was obtained for transcript T2. For each of
the three transcripts, the TSS was determined to be a G
residue, which is the most commonly used residue type
for mycobacterial TSS’s (Figure 4) [26]. For each of the T6,
T11 and T25 transcripts, expression of the asRNAs was
linked to the presence of a SNP (C to T) proximal to
the 5′ end of the asRNA. Strains exhibiting the ‘C’ allele
showed no expression of the asRNA, whilst the strain
that showed expression had the ‘T’ allele. An analysis of
the nucleotide sequence in the vicinity of the SNPs
reveals that for each of the three transcripts the SNP
constitutes the 6th residue of a motif that has strong
homology to the consensus sequence for the −10 element
of Group A mycobacterial promoters (Figure 4) [26]. The
finding that a ‘T’ residue is associated with expression is
consistent with the consensus sequence which indicates
that 86% of all −10 elements have a ‘T’ residue at the 6th
residue position. Several residues that flank the −10 motif
also show a degree of conservation. Sequence motifs
which show strong homology to group A −35 elements
are present 18–19 bp upstream of the putative −10
elements, and the distances between the −35, -10 and
TSS elements are consistent with those elements of
the consensus sequence. No protein encoding open
reading frames were detected within the T6, T11 and
T25 transcripts.
In a parallel study, high density oligonucleotide micro-
arrays were also used to interrogate the transcriptomes
of M. tuberculosis H37Rv, M. bovis BCG Pasteur, Myco-
bacterium caprae and M. bovis AN5 that had been
grown in Middlebrook 7H9 media. As a result of these
experiments, two asRNA species were found to be
Figure 3 Expressions and schematic representation of genomic locations of selected cis-encoded antisense sRNAs identified using a
tiled oligonucleotide microarray. Three asRNAs (open arrows) are (a) T6, (b) T14 and (c) T25. For each asRNA, a histogram plots the fold
changes for each of the oligonucleotide probes that detected the asRNA, and for each probe the binding position relative to the 2122/97
genome is indicated. Closed and open arrows indicate lengths and direction of transcription of genes and asRNAs, respectively.
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narH genes of M. tuberculosis H37Rv, but not in any of
the other 3 strains tested (data not shown). A compari-
son of nucleotide sequences of the orthologous genes
across the species suggested that expressions of the
as_sRNAs correlated with the presence of a sSNP (C to Ttransition at positions 50555 and 1292100 wrt H37Rv
genomic sequence for as_ino1 and as_narH, respectively)
upstream of the asRNAs. Approximate information re-
garding the transcriptional start site was deduced from the
binding co-ordinates of the probes that detected the tran-
scripts. As with the M. bovis antisense sRNAs described
Table 6 Determination of transcriptional start sites of
antisense RNAs
Transcript asRNA PCR
prod. size
TSS
residue type
TSS residue postn
(wrt 2122/97)
T6 mb1618c_as 150 G 1778886
T11 mb1914c_as 220 G 2122978
T25 echA21_as 175 G 4155796
Golby et al. BMC Genomics 2013, 14:710 Page 13 of 18
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the M. tuberculosis asRNAs is part of a putative −10
element. A −35 element with an appropriate spacing to
the −10 element was identified for as_ino1, but not for
as_narH, suggesting that the as_narH promoter may
belong to group B mycobacterial promoters that have
a conserved −10, but no −35 motif [26].
Discussions
The aim of this work was to define possible phenotypic
variation across M. bovis field isolates through a combin-
ation of genome sequencing, comparative genomics and
transcriptome analyses from both in vitro and ex vivo con-
ditions. Using these approaches we uncovered a range of
novel findings, the most striking of which was the realisa-
tion that genes that had been predicted to be differentially
expressed based on amplicon-microarray data were in factFigure 4 Promoters of anti sense RNAs. a. Promoters of the asRNAs as_
indicated in bold and italics. Transcriptional start sites are indicated by larg
the asRNA is indicated by a large font red T residue. The consensus sequen
subscripts indicate the percentage of the total number of promoters for w
that show the indicated residue. b. Promoters of the differentially expresse
are indicated in bold italics. The red residue indicates SNP responsible for dnot upregulated, and that instead it was an antisense tran-
script that was showing differential expression. Analysing
both transcriptome and genome sequence data allowed us
to identify SNPs responsible for the transcription of anti-
sense RNAs, with generation of a consensus −10 promoter
sequence the likely mechanism. Our results suggest that
data generated from amplicon arrays in the past may need
to be revisited, as it is possible that some coding-
sequences identified as being differentially expressed were
instead antisense transcripts.
With the growth of technologies such as high density
tiled oligonucleotide microarrays and next generation
sequencing there has been a rapid increase in the num-
ber of reports describing the existence of non-coding
RNAs (ncRNAs) in bacteria. Non-coding RNAs broadly
consist of two types, cis- and trans-encoded RNA. Trans
RNA includes intergenic encoded RNA, while cis-encoded
RNA includes 5′ and 3′ untranslated regions of mRNA
and antisense RNA. To study the expressions of both cis-
and trans encoded ncRNA we used a high density oligo-
nucleotide tiled microarray since our amplicon microarray
was unable to detect intergenic transcripts or differentiate
between sense and antisense transcripts. Previous studies
using M. tuberculosis have identified substantial amounts
of ncRNA encoded in both intergenic and intragenic re-
gions [7,8]. We detected substantial amounts of ncRNAsmb1618c, as_1914c and as_echA21. -10 and −35 elements are
e font G characters, while SNP residue that leads to the expression of
ce for group a mycobacterial promoters is indicated. Numerical
hich a transcriptional start site has been experimentally determined
d asRNAs as_ino1 and as_narH in M. tuberculosis. -10 and −35 elements
ifferential expression.
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RNA species. Due to their perfect complementarity, cis
asRNA form a duplex with the sense strand encoded
transcript resulting in either degradation [27] or transla-
tion inhibition [28] of the sense mRNA. Antisense
RNAs vary in length, ranging from 10s to 1000′s of
nucleotides and can be classified according to their
encoded position with respect to the opposite sense
encoded gene. Thus, they can be classified as 5′ or 3′
overlapping, while others are classified as internally
located. The 1121/01 specific as_Mb1618c is an example
of a 5′ overlapping asRNA, which is encoded antisense to
gene Mb1618c which is predicted to express a secretory
lipase. The location of the asRNA transcript suggests it
may function to prevent translation of Mb1618c mRNA
by steric hindrance of the ribosome binding site.
In the work presented here strain 2451/01 expressed
two asRNAs, as_Mb1914c and as_echA21, that are not
expressed by any of the other 3 strains. They are
encoded within the central part of the opposite genes
and are therefore likely to modulate the stability of the
transcripts. Mb1914c encodes a short chain dehydro-
genase while echA21 encodes an enoyl-CoA hydratase.
Short chain dehydrogenases catalyse a wide range of
functions so the precise function and identity of the
substrate is difficult to deduce from sequence alone.
Enoyl-CoA hydratases hydrate double carbon-carbon
bonds of macromolecules and are vital in the metabol-
ism of fatty acids. Both gene products would therefore
appear to be involved in the metabolism of a macromol-
ecule and their similar expression profiles in this strain
could indicate involvement in the metabolism of the same
molecule, or molecules that are of the same pathway.
In many instances, upregulation of asRNA negatively
correlates with the transcription of the antisense gene
[27], but in many cases expression of the antisense tran-
script has no effect on the transcription of the opposite
gene. In our studies, expressions of as_Mb1618c,
as_Mb1914c and as_echA21 did not appear to have any
effect on the expressions of the opposite sense encoded
genes (data not shown). We have shown that the
expressions of the asRNAs are associated with the pres-
ence of SNPs, which are either synonymous or non-
synonymous with respect to the sense transcript, but
upstream of the asRNA transcriptional start site. This
highlights the fact that mutations can potentially affect
expression of transcripts on both strands, and that the
classification of a SNP is strand dependent. For each of
the three asRNAs, the associated SNP was found to be
located within a putative −10 promoter motif of group
A mycobacterial promoters. The sixth residue of the −10
hexamer motif consensus sequence is a strongly conserved
‘T’ residue, which is present in 81% of all group A myco-
bacterial promoter elements. Its importance is underlinedby the finding that the strains that exhibit a ‘C’ residue at
this position show no detectable expression of the asRNA,
while strains having a ‘T’ residue at this position exhibit
expression.
Single nucleotide polymorphisms were found to be
the most frequent form of genetic variation that exists
between the isolates, with a total of 1013 SNPs detected
across the three strains 1121/01, 2451/01 and 1307/01
compared to the reference strain M. bovis 2122/97.
Non-synonymous SNPs, which include both non-sense
and missense SNPs, are a class of SNPs most likely to
impact on protein function and contribute to phenotypic
variation. Non-sense SNPs, which results in the expression
of a truncated polypeptide due to the introduction of a
premature stop codon, were identified in five genes across
the strains. Of these, we focussed our attentions on the
non-sense SNP present in a gene encoding the LysR regu-
lator, Mb2007c as mutations affecting regulators are likely
to impact on the expression of one or more genes that are
part of the regulon of the regulator and are therefore more
likely to result in phenotypic variation. Experiments to
compare the transcriptomes of a strain that exhibited the
mutation with a strain overexpressing a functional regula-
tor did not, however, reveal any differences. The reason
for this unclear, but could reflect a requirement of the
regulator for a co-inducer that was absent under the con-
ditions of the experiment. The consequences of missense
SNPs are more difficult to predict, as substitutions of one
amino acid for another in a protein sequence do not ne-
cessarily lead to a change in protein function. However,
for genes that are controlled by an autoregulatory mech-
anism, a mutation that affects the ability of the product of
the gene to regulate itself will result in a change in expres-
sion of the gene. In our studies, we have shown that the
presence of a missense mutation in a VapB type toxin en-
coding gene Mb1749c in strain 1307/01 results in the
upregulation in expression of the toxin-antitoxin encoding
pair of genes Mb1750c-Mb1749c due to the inability of
the encoded proteins to self regulate themselves. Toxin-
antitoxin systems have a variety of proposed cellular func-
tions including general regulation of mRNA stability levels
in the cell [29]. Further experiments are required to fully
understand the consequences of this mutation.
Genomic deletions have played an important role in
the evolution of strains belonging to the mycobacterial
complex [30], and in the derivation of the tuberculosis
vaccine strain M. bovis BCG [31]. In addition to the previ-
ously described 6.8 kb gene deletion that is specific to
strains having a spoligotype 17 pattern [6], we have identi-
fied a 1.6 kb multi-gene deletion that is specific to strain
1307/01 and encompasses genes that are part of the DosR
regulon. However, one of the deleted genes exists as a
pseudo gene in DosR in strain 2122/97, so its importance
to the biology of M. bovis is unlikely to be significant.
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but none of the encoded proteins have any significant
similarity to any protein with a defined function.
Conclusions
In conclusion we have performed a comprehensive ana-
lysis of 4 M. bovis strains of the most common molecular
types circulating in GB. We show that while these strains
show extensive similarities in their genetic make-up and
gene expression profiles, they show distinct differences in
the expression of a subset of genes. We provide functional
data to show that SNPs can lead to the expression of anti-
sense RNA, a finding with implications for how we define
a ‘silent’ nucleotide change. Furthermore, we show that
the interpretation of transcriptome data based solely on
amplicon arrays could lead to artefacts due to expression
of antisense transcripts, a caveat that needs to be kept in
mind for previous studies of global expression analysis in
bacteria.
Methods
Bacterial strains, media and growth conditions
For the Mϕ infection experiments, bovine alveolar Mϕ
were cultivated in tissue culture media R10, which
consisted of RPMI (Invitrogen) media plus 2 mM glu-
tamine, 10% calf fetal serum and 1% amphotericin.
Where used, antibiotics gentamycin and ampicillin
were added at concentrations of 50 and 100 μg / ml,
respectively. M. bovis field strains were pre-grown in
Middlebrook 7H9 broth supplemented with 10% albumin-
dextrose catalase (ADC, Difco), 0.05% Tween and 10 mM
pyruvate. Cultures were harvested in mid-logarithmic
phase (OD600 of 0.3-0.8), washed and then resuspended in
RPMI containing 0.05% Tween 80.
Isolation of bovine alveolar macrophages and infection
with mycobacteria
The lungs of a 6–8 week old male Holstein-Friesian calf
were removed and a whole lung lavage procedure was
performed to washout the alveolar Mϕ. Briefly, 4–5 x
500 ml aliquots of Hanks’ Balanced Sterile Salts solution
(HBSS) were used to infuse the lungs via the trachea,
and the washings were pooled in a sterile beaker. The Mϕ
cells contained in the washes were pelleted by centrifuga-
tion at 500 x g for 10 mins at 4°C, washed and then
resuspended in R10 growth media supplemented with
antibiotics (R10+) to a concentration of 1–2 x 107 / ml.
Approximately 0.5-1.5 x 109 Mϕ were isolated per calf
lung.
Vented 225 cm2 tissue culture flasks containing R10+
media were seeded with 3–4 x 107 alveolar Mϕ and
placed in a humidified 37°C incubator containing 5%
CO2. Typically, 2–4 flasks were used per strain and time
point. After 24 hrs, the growth media was decanted toremove non-adherent cells and then replaced with fresh
R10+ media. After a further 24 hrs, the growth media
was discarded and the Mϕ monolayer was washed with
RPMI to remove traces of the antibiotic containing
growth media. The monolayer was then covered with
R10 media without antibiotics (R10-) and then infected
with mid-logarithmic phase grown mycobacteria using
an MOI of approximately 10:1 (bacilli: Mϕ). The AlvMϕ
were incubated with mycobacteria for 4 hrs, after which
the cell monolayers were washed with RPMI and then
either processed for RNA extraction (4 hr time point)
or incubated in fresh R10+ media for a further 20 hrs
before being processed for RNA extraction (24 hr time
point).
Extraction and amplification of mycobacterial RNA from
infected macrophages
Mϕ cell monolayers were lysed using a guanidinium
thiocyanate (GTC) containing solution. The lysed Mϕ’s
were vortexed and passed twice through a 21G blunt
ended needle to sheer host genomic DNA and thereby
reduce the viscosity of the solution. Mycobacterial cells
were then pelleted by centrifugation at 4600 rpm for 20
mins at room temperature and washed with GTC solu-
tion to remove host genomic DNA. Cells were then
resuspended in Trizol and RNA was extracted using the
protocol outlined in Bacon et al. [32]. The amount of
purified DNase-treated RNA recovered was of the order
100–500 ng per time point. RNA was amplified using
the ‘MessageAmp II-Bacteria RNA Amplification Kit’
(Ambion) according to the manufacturers’ instructions.
Using an input of 100 ng of unamplified RNA, 20–100
μg of amplified RNA was recovered.
Amplicon microarray analysis
For the in vitro growth experiments, three independent
experiments (biological replicates) were carried out, and
for each strain in each experiment two microarrays (tech-
nical replicates) were performed. Thus, for each strain 6
microarrays were performed. Three independent AlvMϕ
infection experiments were carried out and for each
experiment two microarrays were performed for each of
the control RPMI samples, and the 4- and 24 hrs post-
infection samples. Cy5 and Cy3 fluorescently-labelled
probes were synthesised from RNA and genomic
DNA, respectively, and hybridised to whole genome
M. bovis / M. tuberculosis microarrays. The array design
is available in BμG@Sbase (accession number A-BUGS-31;
http://bugs.sgul.ac.uk/A-BUGS-31) and also ArrayExpress
(accession number A-BUGS-31). Details of probe synthesis,
hybridization conditions and manufacture of the micro-
array can be found in Golby et al. 2008. Microarrays
were scanned using an Affymetrix 428 Microarray
scanner and scanned images were quantified using
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See Golby et al. 2008 for further details.
Normalisation was performed by dividing the log ratio
of the Cy5 to Cy3 signal for every spot by the median of
the log ratios for all spots, except control spots. A median
absolute (MAD) scale transformation was applied to the
normalised data from the pas an additional normalisation
step. For every microarray, duplicate spots were averaged,
and then the average expression of every gene across all
technical replicate microarrays was calculated. Averages
of the three biological replicates were used to compare
gene expression between strains. For each gene, a mod-
erated t-test was applied and those genes with a P- value
less than 0.05 were selected. From this gene list, those
genes whose average expression differed by more than
2.5-fold between strains were selected. Fully annotated
microarray data have been deposited in BμG@Sbase (acces-
sion number: E-BUGS-150; http://bugs.sgul.ac.uk/E-BUGS-
150) and also ArrayExpress (accession number: E-BUGS-
150).
Oligonucleotide microarray analysis
Experiments were performed in a similar way to that
described for the in vitro amplicon array experiments,
except that the RNA was purified using the mirVana
miRNA Isolation kit (Ambion), which is designed to
capture small (>20 nt) RNA species. RNA and genomic
DNA were directly labelled with Cy5- and Cy3, respect-
ively, using the ULS microRNA labelling kit (Kreatech),
according to the manufacturer’s instructions. Purified
Cy5- and Cy3-labelled probes were co-purified and
applied to an Agilent 40K custom made tiled (10 nt
overlap) 60-mer oligonucleotide microarray designed to
the genomic sequence of M. bovis 2122/97/97. The array
design is available in BμG@Sbase (accession number
A-BUGS-52; http://bugs.sgul.ac.uk/A-BUGS-52) and also
ArrayExpress (accession number A-BUGS-52). Microarrays
were hybridised at 65°C for 18 hrs and then washed in
Wash Buffer 1 (Agilent) at room temperature for 1 minute.
The slides were then washed in Wash Buffer 2 (Agilent) at
37°C for 1 minute, dried and then scanned at 2 μm using
an Agilent DNA microarray scanner.
Tiling array data was analysed using the Limma package
of R/Bioconductor [33]. The signal median was quan-
tile normalised between arrays followed by a LOESS
normalisation within arrays. Differential expression
analysis was performed by pairwise comparison using
linear models and empirical Bayes methods, and P
values adjusted using the Benjamini and Hochberg's
method to control for multiple testing. Fully annotated
microarray data have been deposited in BμG@Sbase
(accession number: E-BUGS-150; http://bugs.sgul.ac.
uk/E-BUGS-150) and also ArrayExpress (accession num-
ber: E-BUGS-150).Whole genome sequencing of M. bovis field isolates
Whole genome paired end (2 x 76bp) sequencing was
performed using Illumina HiSeq machines at the
Wellcome Trust Sanger Institute (Hinxton, Cambridge).
Raw sequence data was uploaded to the European Nucleo-
tide Archive (ENA) and can be downloaded at http://www.
ebi.ac.uk/ena/, accession numbers: ERX006616, ERX06617,
ERX012284 and ERX012286. The FastQC (http://www.
bioinformatics.babraham.ac.uk/projects/fastqc) program
was used to analyse the quality of the raw data reads. Raw
sequence data was trimmed to remove adapter sequences
and nucleotides where the sequence quality score was
below 20. Filtered reads were aligned to the M. bovis refer-
ence strain 2122/97 [10] with the SMALT alignment
program (http://www.sanger.ac.uk/resources/software/smalt)
using default settings. The average mean coverages for the
sequenced strains 1121/01, 2451/01 and 1307/01 were
293, 224 and 234, respectively. Reads that did not map
onto the reference genome were de novo assembled and
blasted against the NCBI data base in order to find regions
present in these strains but absent in 2122/01. Variant
calling and the generation of consensus sequences
were carried out using the SAMtools program suite
(http://samtools.sourceforge.net). SNPs that had a mini-
mum of quality score of 200 and had a minimum of four
good quality forward (reverse) reads covering the SNP site
and having the variant base were retained. The number of
forward (reverse) reads mapping with good quality onto
the SNP site having the same base as in the reference had
to be less than 5% of the total number of forward (reverse)
reads mapping with good quality onto the SNP site having
the variant base. Sequences of 12 bases in length centred
around SNP sites were blasted to the genome of the refer-
ence strain 2122/97, and any SNP within an area with a
90% hit to another area of the genome were filtered out.
This eliminated most of the SNPs within the repetitive
PE-PGRS regions. For all sequenced strains, more than
99.9% of the genomes were covered by reads.
Real time RT-PCR
Quantitative real-time SYBR Green based PCR (qRT-PCR)
experiments were performed using a RotorGene 3000
(Corbett research) as described by Golby et al. [23]. Fold
changes were calculated using relative standard curve
method and pcr controls included no template and no
reverse transcriptase. Primer pair sequences are given in
Additional file 5, available with the online version of
this paper.
Construction of the Rv1749c-Rv1750c and nirBD
overexpressing plasmids
The Rv1749c-Rv1750c overexpressing plasmids pPG106
and pPG107 were constructed by PCR amplification of a
907bp fragment encompassing Rv1749c-Rv1750c-‘Rv1751c
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http://www.biomedcentral.com/1471-2164/14/710using primers tox_f and tox_r. For pPG106, the fragment
was amplified using 2122/97/97 genomic DNA as a tem-
plate, while pPG107 was amplified using 1307/01 gDNA.
Both fragments were digested with SpeI and cloned into
the SpeI cut mycobacterial attP-integrating shuttle vector
pKINT (a gift from Douglas Young, Imperial College,
London). Plasmids pPG108 and pPG109, which contain a
3.5 kb hsp’-nirB-nirD-‘cobU fragment was constructed in
several steps. Firstly, two 1.6 kb hsp’-nirB’ PCR fragments
were PCR amplified separately using primers nirB1_f and
nirB1_r and 2122/97 and 1307/01 as genomic templates.
Similarly, two 1.8kb ‘nirB-nirD-‘cobU fragments were
amplified using primers nirB2_f and nirB2_r and genomic
DNAs 2122/97 and 1307/01. The two PCR products were
digested with SpeI and BamHI and then co-ligated into
pKINT. Details concerning the nucleotide sequences of
the pcr primer pairs are given in the Additional file 5.5′-RLM-RACE PCR
Transcriptional start site mapping of was determined
using the First Choice RNA ligase-mediated rapid amp-
lification of cDNA ends (RLM-RACE) kit (Ambion) as
per manufacturers instructions. Briefly, 10 ug of total
RNA was treated with calf intestinal phosphatase (CIP)
and tobacco acid pyrophosphatase (TAP) before ligation
of an RNA Adapter oligonucleotide to the 5′ ends of
the mRNA transcripts. A random-primed reverse tran-
scription reaction was carried out to generate cDNA
and then nested PCR reactions were performed on the
cDNA using combinations of adapter and gene specific
primers. Details concerning the nucleotide sequences
of the 5′ outer and inner adapter sequences as well as
3′ outer and inner gene specific primers are given in
the Additional file 5. PCR products generated using
the 5′ inner adapter and 3′ inner gene specific primers
were sequenced by Sanger sequencing using the 3′ inner
gene specific primer.Animal ethics statement
Animal work was carried out according to the UK Animal
(Scientific Procedures) Act 1986. The study protocol was
approved by the AHVLA Animal Use Ethics Committee
(UK Home Office PCD number 70/6905).Availability of supporting data section
Fully annotated microarray data have been deposited in
BμG@Sbase (accession number: E-BUGS-150; http://
bugs.sgul.ac.uk/E-BUGS-150) and also ArrayExpress (ac-
cession number: E-BUGS-150). Raw sequence data was
uploaded to the European Nucleotide Archive (ENA) and
can be downloaded at http://www.ebi.ac.uk/ena/data/view/
ERX006616-ERX06617,ERX012284-ERX012286.Additional files
Additional file 1: SNPs identified across sequenced strains.
Additional file 2: Large deletions identified by NGS in sequenced
strains.
Additional file 3: Fold change differences in gene expression in
M. bovis field isolates 1121, 2451 and 1307 compared to 2122.
Cells shaded in red indicate upregulation, green indicate down-
regulation and empty cells indicate no change in expression.
Additional file 4: Differential expression of RNA transcripts as
detected by a tiled oligonucleotide microarray. Up and down arrows
indicate fold up- and downregulation, respectively, and empty cells
indicate no change in expression. *Strand, A indicates antisense, S, sense
and I, intergenic.
Additional file 5: Details of oligonucleotides used in PCR, RT-PCR
and RLM-RACE experiments.
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